Mesirow Financial Investment Management, Inc. Oncocyte Corp Transaction History

Mesirow Financial Investment Management, Inc.

  • $4.79 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 13, 2020
SELL
$1.2 - $1.89 $119,138 - $187,642
-99,282 Closed
0 $0
Q2 2020

Jul 22, 2020
SELL
$1.91 - $3.45 $299 - $541
-157 Reduced 0.16%
99,282 $190,000
Q1 2020

Apr 09, 2020
SELL
$1.76 - $3.02 $110,147 - $189,003
-62,584 Reduced 38.63%
99,439 $244,000
Q4 2019

Jan 09, 2020
SELL
$1.51 - $2.27 $9,439 - $14,189
-6,251 Reduced 3.71%
162,023 $365,000
Q3 2019

Oct 30, 2019
BUY
$1.59 - $2.51 $267,555 - $422,367
168,274 New
168,274 $353,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
399K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $238M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email